Verastem, Inc. (0LOV.L)

USD 7.13

(-2.45%)

Eps Summary of Verastem, Inc.

  • Verastem, Inc.'s latest annual eps in 2023 was -3.96 USD , up 13.54% from previous year.
  • Verastem, Inc.'s latest quarterly eps in 2024 Q2 was -0.31 USD , up 75.4% from previous quarter.
  • Verastem, Inc. reported an annual eps of -4.58 USD in 2022, up 17.92% from previous year.
  • Verastem, Inc. reported an annual eps of -5.58 USD in 2021, down -5.28% from previous year.
  • Verastem, Inc. reported a quarterly eps of -0.31 USD for 2024 Q2, up 75.4% from previous quarter.
  • Verastem, Inc. reported a quarterly eps of N/A for 2023 FY, up 13.54% from previous quarter.

Annual Eps Chart of Verastem, Inc. (2023 - 2011)

Historical Annual Eps of Verastem, Inc. (2023 - 2011)

Year Eps Eps Growth
2023 -3.96 USD 13.54%
2022 -4.58 USD 17.92%
2021 -5.58 USD -5.28%
2020 -5.30 USD 80.53%
2019 -27.22 USD -117.07%
2018 -12.54 USD 40.79%
2017 -21.18 USD -79.19%
2016 -11.82 USD 38.82%
2015 -19.32 USD 22.16%
2014 -24.82 USD -13.85%
2013 -21.80 USD -6.6%
2012 -20.45 USD -152.16%
2011 -8.11 USD 0.0%

Peer Eps Comparison of Verastem, Inc.

Name Eps Eps Difference
BioMarin Pharmaceutical Inc. 0.89 USD 544.944%
Aclaris Therapeutics, Inc. -1.27 USD -211.811%
Myriad Genetics, Inc. -1.39 USD -184.892%
Evolus, Inc. -1.08 USD -266.667%
Ionis Pharmaceuticals, Inc. -2.56 USD -54.688%
Agilent Technologies, Inc. 4.22 USD 193.839%
Agios Pharmaceuticals, Inc. -6.33 USD 37.441%
uniQure N.V. -6.47 USD 38.794%
Anavex Life Sciences Corp. -0.60 USD -560.0%
Atara Biotherapeutics, Inc. -65.18 USD 93.925%
bluebird bio, Inc. -1.93 USD -105.181%
Abeona Therapeutics Inc. -2.53 USD -56.522%
Alnylam Pharmaceuticals, Inc. -3.52 USD -12.5%
Corcept Therapeutics Incorporated 1.02 USD 488.235%
Amicus Therapeutics, Inc. -0.51 USD -676.471%
Dynavax Technologies Corporation -0.05 USD -7883.871%
Editas Medicine, Inc. -2.02 USD -96.04%
FibroGen, Inc. -2.92 USD -35.616%
Geron Corporation -0.32 USD -1137.5%
Blueprint Medicines Corporation -8.37 USD 52.688%
IQVIA Holdings Inc. 7.39 USD 153.586%
Illumina, Inc. -7.35 USD 46.122%
Iovance Biotherapeutics, Inc. -1.89 USD -109.524%
Kala Pharmaceuticals, Inc. -17.35 USD 77.176%
Neurocrine Biosciences, Inc. 2.56 USD 254.688%
Cara Therapeutics, Inc. -2.19 USD -80.822%
Adicet Bio, Inc. -3.31 USD -19.637%
Sarepta Therapeutics, Inc. -5.80 USD 31.724%
Insmed Incorporated -5.34 USD 25.843%
Intellia Therapeutics, Inc. -5.42 USD 26.937%
Mettler-Toledo International Inc. 36.10 USD 110.97%
Unity Biotechnology, Inc. -2.70 USD -46.667%
Supernus Pharmaceuticals, Inc. 0.02 USD 16531.535%
Walgreens Boots Alliance, Inc. -10.01 USD 60.44%
Waters Corporation 10.87 USD 136.431%
Zoetis Inc. 5.08 USD 177.953%
Thermo Fisher Scientific Inc. 15.53 USD 125.499%
Biogen Inc. 8.02 USD 149.377%
Sangamo Therapeutics, Inc. -1.48 USD -167.568%
Nektar Therapeutics -1.45 USD -173.103%
Viking Therapeutics, Inc. -0.91 USD -335.165%
Perrigo Company plc -0.09 USD -4117.252%
Axsome Therapeutics, Inc. -5.27 USD 24.858%
Heron Therapeutics, Inc. -0.80 USD -395.0%
Vertex Pharmaceuticals Incorporated 14.05 USD 128.185%
Imunon, Inc. -2.16 USD -83.333%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 61.591%
Esperion Therapeutics, Inc. -2.03 USD -95.074%
Homology Medicines, Inc. -7.41 USD 46.559%
Regeneron Pharmaceuticals, Inc. 37.05 USD 110.688%
OPKO Health, Inc. -0.25 USD -1484.0%
Exelixis, Inc. 0.65 USD 709.231%
Halozyme Therapeutics, Inc. 2.13 USD 285.915%
TG Therapeutics, Inc. 0.09 USD 4534.49%
Incyte Corporation 2.67 USD 248.315%
Emergent BioSolutions Inc. -14.85 USD 73.333%